Evan Albright
digest / work
All tags

#chatbots

2 digests

2026

  • Lilly paid up to $2.875B for an autoimmune antibody program
    Eli Lilly moved into selective degradation of pathogenic autoantibodies with a deal worth up to $2.875B. Elsewhere, open-weight AI models grew markedly in scale, ChatGPT advertising reached a $1B annualized run rate, and data from hundreds of thousands of businesses showed AI use climbing without an apparent employment shock so far.
    Aug 31, 2026
  • Claude returns from export control limbo as Cloudflare opens agent toll roads
    Anthropic's Claude Sonnet 5 shipped on June 30 and Fable 5 returned globally on July 1 after the Department of Commerce lifted export controls that had restricted access for 19 days. Cloudflare declared a second Content Independence Day, launching a Monetization Gateway that lets site owners charge AI agents for any resource via stablecoin settlement over the x402 protocol, and released new granular controls to distinguish search bots from training bots. The FDA granted a historic clearance to an LLM-based diabetes management app, prompting debate about whether the model is an interface or a clinical decision-maker. Biotech stocks have now rallied for 15 consecutive months. The U.S. Department of Transportation proposed the first update to supersonic flight rules since the 1970s, opening the door to civilian supersonic travel.
    Jul 02, 2026
© 2026 | Evan Albright